X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (154169) 154169
Publication (8054) 8054
Newsletter (1585) 1585
Book Review (587) 587
Magazine Article (496) 496
Book Chapter (232) 232
Dissertation (167) 167
Conference Proceeding (126) 126
Book / eBook (38) 38
Web Resource (16) 16
Newspaper Article (9) 9
Data Set (7) 7
Trade Publication Article (7) 7
Reference (6) 6
Presentation (3) 3
Streaming Video (3) 3
Government Document (2) 2
Journal / eJournal (2) 2
Report (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (140998) 140998
female (86395) 86395
male (78336) 78336
middle aged (74259) 74259
aged (62996) 62996
carcinoma, squamous cell - pathology (52293) 52293
adult (51394) 51394
index medicus (48637) 48637
oncology (40762) 40762
cancer (33791) 33791
squamous cell carcinoma (30296) 30296
squamous-cell carcinoma (27587) 27587
carcinoma, squamous cell - surgery (25558) 25558
prognosis (24867) 24867
aged, 80 and over (23013) 23013
surgery (20742) 20742
neoplasm staging (19761) 19761
retrospective studies (16883) 16883
carcinoma, squamous cell - genetics (15093) 15093
animals (14892) 14892
carcinoma, squamous cell - metabolism (14637) 14637
carcinoma, squamous cell - radiotherapy (14404) 14404
carcinoma, squamous cell - drug therapy (13680) 13680
carcinoma, squamous cell - mortality (13341) 13341
carcinoma, squamous cell - diagnosis (13041) 13041
immunohistochemistry (12501) 12501
carcinoma (12450) 12450
treatment outcome (12239) 12239
carcinoma, squamous cell - therapy (12123) 12123
follow-up studies (11871) 11871
radiotherapy (11813) 11813
head (11718) 11718
lymphatic metastasis (11335) 11335
tumors (11045) 11045
risk factors (10903) 10903
expression (10798) 10798
chemotherapy (10234) 10234
survival rate (10220) 10220
research (10118) 10118
pathology (10031) 10031
metastasis (9943) 9943
otorhinolaryngology (9819) 9819
analysis (9622) 9622
care and treatment (9529) 9529
adenocarcinoma - pathology (9498) 9498
combined modality therapy (9361) 9361
head and neck neoplasms - pathology (9003) 9003
survival (8869) 8869
esophageal neoplasms - pathology (8485) 8485
lung neoplasms - pathology (8451) 8451
carcinoma, squamous cell - secondary (8397) 8397
mice (8351) 8351
cell line, tumor (8301) 8301
mouth neoplasms - pathology (7901) 7901
uterine cervical neoplasms - pathology (7485) 7485
head and neck cancer (7380) 7380
esophageal cancer (7061) 7061
neoplasm invasiveness (6849) 6849
carcinoma, squamous cell - epidemiology (6733) 6733
skin neoplasms - pathology (6631) 6631
health aspects (6605) 6605
dentistry, oral surgery & medicine (6540) 6540
survival analysis (6394) 6394
time factors (6380) 6380
antineoplastic combined chemotherapy protocols - therapeutic use (6365) 6365
diagnosis (6304) 6304
radiology, nuclear medicine & medical imaging (6247) 6247
adolescent (6102) 6102
gene expression regulation, neoplastic (6036) 6036
carcinoma, squamous cell (5966) 5966
adenocarcinoma (5946) 5946
apoptosis (5865) 5865
carcinoma, squamous cell - diagnostic imaging (5680) 5680
carcinoma, squamous cell - etiology (5646) 5646
neck-cancer (5619) 5619
diagnosis, differential (5613) 5613
carcinoma, squamous cell - complications (5610) 5610
biopsy (5577) 5577
neck (5465) 5465
disease-free survival (5452) 5452
medicine & public health (5379) 5379
prospective studies (5148) 5148
neoplasm metastasis (5120) 5120
dermatology (5034) 5034
lung cancer (5011) 5011
radiotherapy dosage (4977) 4977
genetic aspects (4908) 4908
gene expression (4897) 4897
case-control studies (4896) 4896
cervical cancer (4896) 4896
esophageal neoplasms - surgery (4877) 4877
breast-cancer (4864) 4864
hematology, oncology and palliative medicine (4864) 4864
adenocarcinoma - surgery (4851) 4851
cell biology (4839) 4839
risk (4812) 4812
radiation-therapy (4799) 4799
head and neck neoplasms - drug therapy (4705) 4705
therapy (4518) 4518
laryngeal neoplasms - pathology (4471) 4471
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Markham Stouffville Hospital - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (138133) 138133
Japanese (4594) 4594
German (4542) 4542
Chinese (3915) 3915
French (3012) 3012
Russian (1900) 1900
Spanish (1305) 1305
Italian (1216) 1216
Polish (862) 862
Portuguese (403) 403
Dutch (164) 164
Hungarian (128) 128
Czech (120) 120
Korean (117) 117
Romanian (100) 100
Turkish (100) 100
Danish (87) 87
Hebrew (57) 57
Bulgarian (55) 55
Croatian (50) 50
Swedish (46) 46
Serbian (44) 44
Norwegian (41) 41
Finnish (30) 30
Slovak (17) 17
Ukrainian (17) 17
Greek (16) 16
Lithuanian (14) 14
Icelandic (4) 4
Persian (4) 4
Arabic (3) 3
Afrikaans (2) 2
Latvian (2) 2
Thai (2) 2
Amharic (1) 1
Bosnian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 9, pp. 1566 - 1575
BACKGROUND Human papillomavirus (HPV) is a well‐established prognostic marker for oropharyngeal squamous cell cancer (OPSCC). Because of the limited numbers of... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | UNITED-STATES | POSITIVE HEAD | IN-SITU HYBRIDIZATION | IMPROVED SURVIVAL | TRIAL | NASOPHARYNGEAL CARCINOMA | HPV STATUS | THERAPY | ONCOLOGY | IMMUNOHISTOCHEMISTRY | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Risk groups | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 291 - 298
Purpose To update the Memorial Sloan-Kettering Cancer Center’s experience with intensity-modulated radiotherapy (IMRT) in the treatment of oropharyngeal cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Dysphagia | IMRT | Xerostomia | Oropharyngeal cancer | HEAD | SPARING RADIOTHERAPY | NECK-CANCER | RADIATION-THERAPY | SALIVARY-GLAND FUNCTION | IMPACT | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Pharyngeal Neoplasms - radiotherapy | Follow-Up Studies | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Palate, Soft | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Tongue Neoplasms - drug therapy | Incidence | New York City | Palatal Neoplasms - mortality | Treatment Failure | Aged, 80 and over | Adult | Female | Xerostomia - epidemiology | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Tongue Neoplasms - mortality | Tonsillar Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Palatal Neoplasms - radiotherapy | Deglutition Disorders - epidemiology | Palatal Neoplasms - pathology | Oropharyngeal Neoplasms - radiotherapy | Cancer Care Facilities | Tonsillar Neoplasms - mortality | Tongue Neoplasms - pathology | Pharyngeal Neoplasms - mortality | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - drug therapy | Pharyngeal Neoplasms - pathology | Aged | Palatal Neoplasms - drug therapy | Neoplasm Staging | Radiotherapy, Intensity-Modulated | Care and treatment | Throat cancer | Radiotherapy | Nuclear radiation | Cancer | PATIENTS | NEOPLASMS | FAILURES | METASTASES | PLATINUM | RADIATION DOSES | LYMPHATIC SYSTEM | CHEMOTHERAPY | PLANNING | PHARYNX | TONGUE | WOMEN | MEN | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
Seminars in Oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
The fibroblast growth factor receptor (FGFR) pathway plays a major role in several biological processes, from organogenesis to metabolism homeostasis and... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 1, pp. 93 - 105
Abstract The fourth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO “blue book”), published in 2016, contains... 
Urology | Urogenital tract | WHO classification | Male genital organs | SQUAMOUS-CELL-CARCINOMA | TUBULOCYSTIC CARCINOMA | DIFFERENTIATED PAPILLARY MESOTHELIOMA | SPERMATOCYTIC SEMINOMA | PRIMARY PURE TERATOMA | GERM-CELLS | UROLOGY & NEPHROLOGY | GONADAL STROMAL TUMOR | YOLK-SAC TUMOR | IN-SITU | CLINICOPATHOLOGICAL FEATURES | Neoplastic Syndromes, Hereditary - pathology | Uterine Neoplasms - pathology | Carcinoma, Squamous Cell - virology | Humans | Kidney Neoplasms - classification | Carcinoma, Renal Cell - classification | Male | Testicular Neoplasms - pathology | Neoplasm Grading | Leiomyomatosis - pathology | Carcinoma, Renal Cell - enzymology | Uterine Neoplasms - classification | Testicular Neoplasms - classification | Skin Neoplasms - pathology | Penile Neoplasms - virology | Papillomavirus Infections - complications | World Health Organization | Carcinoma, Renal Cell - pathology | Neoplasm Invasiveness | Leiomyomatosis - classification | Succinate Dehydrogenase - deficiency | Skin Neoplasms - classification | Carcinoma, Squamous Cell - classification | Neoplasms, Germ Cell and Embryonal - classification | Kidney Neoplasms - pathology | Penile Neoplasms - classification | Neoplastic Syndromes, Hereditary - classification | Neoplasms, Germ Cell and Embryonal - pathology | Medical colleges | Squamous cell carcinoma | Papillomavirus infections | Tumors
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
Purpose To compare the temporal lymph node (LN) regression and regional control (RC) after primary chemoradiation therapy/radiation therapy in human... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 03/2015, Volume 65, Issue 2, pp. 87 - 108
Journal Article